3Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Br J Haematol, 1998, 102:1115-1123. 被引量：1
4Hernandez MV, Guanabens N, Alvarez L,et al. Immunocytochemical evidence on the effects of glucocorticoids on type I collagen synthesis in human osteoblastic cells. Calcif Tissue Int, 2004,74:284-293. 被引量：1
5Jakob C, Zavrski I, Heider U, et al. Bone resorption parameters [carboxyterminal telopeptide of type- Ⅰ collagen ( ICTP), aminoterminal collagen type- Ⅰ telopeptide ( NTx ), and deoxypyridinoline (Dpd) ] in MGUS and multiple myeloma. Eur J Haematol, 2002,69: 37-42. 被引量：1
6Luftner D, Richter A, Geppert R, et al. Normalisation of biochemical markers of bone formation correlates with clinical benefit from therapy in metastatic breast cancer. Anticancer Res,2003, 23: 1017-1026. 被引量：1
